Listed

Climb Bio, Inc.

CLYMNasdaqCIK 1768446HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$15.4m, Q2 FY2026
Net income−$13.5m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m2.9Research and development, Q3 FY2023, three months to 2023-09-30$2.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0000950170-24-125294.Report this figure3.1Research and development, Q4 FY2023, three months to 2023-12-31$3.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-25, accession 0000950170-25-044350. Derived: 12-month figure less the 9-month figure.Report this figure1.1Research and development, Q1 FY2024, three months to 2024-03-31$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0000950170-25-070902.Report this figure1.0Research and development, Q2 FY2024, three months to 2024-06-30$1.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0000950170-25-106916.Report this figure6.2Research and development, Q3 FY2024, three months to 2024-09-30$6.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-268086.Report this figure6.0Research and development, Q4 FY2024, three months to 2024-12-31$6.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001193125-26-092546. Derived: 12-month figure less the 9-month figure.Report this figure17.3Research and development, Q1 FY2025, three months to 2025-03-31$17.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-210357.Report this figure6.6Research and development, Q2 FY2025, three months to 2025-06-30$6.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure9.1Research and development, Q3 FY2025, three months to 2025-09-30$9.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001193125-25-268086.Report this figure13.7Research and development, Q4 FY2025, three months to 2025-12-31$13.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001193125-26-092546. Derived: 12-month figure less the 9-month figure.Report this figure9.4Research and development, Q1 FY2026, three months to 2026-03-31$9.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-210357.Report this figure9.7Research and development, Q2 FY2026, three months to 2026-06-30$9.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure
Operating income$m(5.0)Operating income, Q3 FY2023, three months to 2023-09-30−$5.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125294.Report this figure(5.1)Operating income, Q4 FY2023, three months to 2023-12-31−$5.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-25, accession 0000950170-25-044350. Derived: 12-month figure less the 9-month figure.Report this figure(3.0)Operating income, Q1 FY2024, three months to 2024-03-31−$3.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0000950170-25-070902.Report this figure(56.4)Operating income, Q2 FY2024, three months to 2024-06-30−$56.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0000950170-25-106916.Report this figure(11.7)Operating income, Q3 FY2024, three months to 2024-09-30−$11.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268086.Report this figure(10.9)Operating income, Q4 FY2024, three months to 2024-12-31−$10.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-092546. Derived: 12-month figure less the 9-month figure.Report this figure(23.0)Operating income, Q1 FY2025, three months to 2025-03-31−$23.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-210357.Report this figure(10.7)Operating income, Q2 FY2025, three months to 2025-06-30−$10.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure(14.9)Operating income, Q3 FY2025, three months to 2025-09-30−$14.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268086.Report this figure(19.3)Operating income, Q4 FY2025, three months to 2025-12-31−$19.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-092546. Derived: 12-month figure less the 9-month figure.Report this figure(15.2)Operating income, Q1 FY2026, three months to 2026-03-31−$15.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-210357.Report this figure(15.4)Operating income, Q2 FY2026, three months to 2026-06-30−$15.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0000950170-24-125294.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-25, accession 0000950170-25-044350. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-14, accession 0000950170-25-070902.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-08-14, accession 0000950170-24-096626. Derived: 6-month figure less the 3-month figure.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0000950170-24-125294.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-05, accession 0001193125-26-092546. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-14, accession 0000950170-25-070902.Report this figurenot reportednot reportednot reportednot reportednot reported
Net income$m(4.0)Net income, Q3 FY2023, three months to 2023-09-30−$4.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125294.Report this figure(3.6)Net income, Q4 FY2023, three months to 2023-12-31−$3.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-25, accession 0000950170-25-044350. Derived: 12-month figure less the 9-month figure.Report this figure(1.7)Net income, Q1 FY2024, three months to 2024-03-31−$1.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268086.Report this figure(54.9)Net income, Q2 FY2024, three months to 2024-06-30−$54.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268086.Report this figure(8.9)Net income, Q3 FY2024, three months to 2024-09-30−$8.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268086.Report this figure(8.4)Net income, Q4 FY2024, three months to 2024-12-31−$8.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-092546. Derived: 12-month figure less the 9-month figure.Report this figure(20.8)Net income, Q1 FY2025, three months to 2025-03-31−$20.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure(8.7)Net income, Q2 FY2025, three months to 2025-06-30−$8.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure(12.9)Net income, Q3 FY2025, three months to 2025-09-30−$12.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-268086.Report this figure(17.5)Net income, Q4 FY2025, three months to 2025-12-31−$17.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001193125-26-092546. Derived: 12-month figure less the 9-month figure.Report this figure(13.7)Net income, Q1 FY2026, three months to 2026-03-31−$13.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure(13.5)Net income, Q2 FY2026, three months to 2026-06-30−$13.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure
Diluted EPS$ per share(0.15)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0000950170-24-125294.Report this figurenot reported(0.06)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0000950170-25-070902.Report this figure(1.81)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$1.81 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0000950170-25-106916.Report this figure(0.13)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-268086.Report this figurenot reported(0.31)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-210357.Report this figure(0.13)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure(0.19)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-268086.Report this figurenot reported(0.20)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-210357.Report this figure(0.18)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure
Basic EPS$ per share(0.15)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0000950170-24-125294.Report this figurenot reported(0.06)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0000950170-25-070902.Report this figure(1.81)Basic EPS, Q2 FY2024, three months to 2024-06-30−$1.81 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0000950170-25-106916.Report this figure(0.13)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-268086.Report this figurenot reported(0.31)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-210357.Report this figure(0.13)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure(0.19)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001193125-25-268086.Report this figurenot reported(0.20)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-210357.Report this figure(0.18)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure

Balance sheet

Cash and equivalents$44.1m, Q2 FY2026
Shareholders' equity$239.5m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m57.4Cash and equivalents, Q3 FY2023, at 2023-09-30$57.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-14, accession 0000950170-23-063675.Report this figure93.1Cash and equivalents, FY2023, at 2023-12-31$93.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-25, accession 0000950170-25-044350.Report this figure105Cash and equivalents, Q1 FY2024, at 2024-03-31$105.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-15, accession 0000950170-24-059995.Report this figure223Cash and equivalents, Q2 FY2024, at 2024-06-30$223.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-14, accession 0000950170-24-096626.Report this figure146Cash and equivalents, Q3 FY2024, at 2024-09-30$146.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0000950170-24-125294.Report this figure87.2Cash and equivalents, FY2024, at 2024-12-31$87.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-05, accession 0001193125-26-092546.Report this figure29.0Cash and equivalents, Q1 FY2025, at 2025-03-31$29.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0000950170-25-070902.Report this figure22.7Cash and equivalents, Q2 FY2025, at 2025-06-30$22.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure25.8Cash and equivalents, Q3 FY2025, at 2025-09-30$25.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001193125-25-268086.Report this figure35.7Cash and equivalents, FY2025, at 2025-12-31$35.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure8.4Cash and equivalents, Q1 FY2026, at 2026-03-31$8.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-210357.Report this figure44.1Cash and equivalents, Q2 FY2026, at 2026-06-30$44.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure
Current assets$m112Current assets, Q3 FY2023, at 2023-09-30$112.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-14, accession 0000950170-23-063675.Report this figure110Current assets, FY2023, at 2023-12-31$110.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-25, accession 0000950170-25-044350.Report this figure109Current assets, Q1 FY2024, at 2024-03-31$109.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-15, accession 0000950170-24-059995.Report this figure226Current assets, Q2 FY2024, at 2024-06-30$226.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0000950170-24-096626.Report this figure198Current assets, Q3 FY2024, at 2024-09-30$197.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125294.Report this figure155Current assets, FY2024, at 2024-12-31$154.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-05, accession 0001193125-26-092546.Report this figure100Current assets, Q1 FY2025, at 2025-03-31$100.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0000950170-25-070902.Report this figure87.4Current assets, Q2 FY2025, at 2025-06-30$87.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0000950170-25-106916.Report this figure91.0Current assets, Q3 FY2025, at 2025-09-30$91.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-268086.Report this figure106Current assets, FY2025, at 2025-12-31$105.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure113Current assets, Q1 FY2026, at 2026-03-31$113.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-210357.Report this figure187Current assets, Q2 FY2026, at 2026-06-30$186.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure
Total assets$m113Total assets, Q3 FY2023, at 2023-09-30$112.7m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-14, accession 0000950170-23-063675.Report this figure110Total assets, FY2023, at 2023-12-31$110.5m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-25, accession 0000950170-25-044350.Report this figure109Total assets, Q1 FY2024, at 2024-03-31$109.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-15, accession 0000950170-24-059995.Report this figure226Total assets, Q2 FY2024, at 2024-06-30$226.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0000950170-24-096626.Report this figure222Total assets, Q3 FY2024, at 2024-09-30$222.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0000950170-24-125294.Report this figure217Total assets, FY2024, at 2024-12-31$217.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-05, accession 0001193125-26-092546.Report this figure201Total assets, Q1 FY2025, at 2025-03-31$200.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0000950170-25-070902.Report this figure192Total assets, Q2 FY2025, at 2025-06-30$192.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0000950170-25-106916.Report this figure182Total assets, Q3 FY2025, at 2025-09-30$182.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001193125-25-268086.Report this figure168Total assets, FY2025, at 2025-12-31$167.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure152Total assets, Q1 FY2026, at 2026-03-31$152.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001193125-26-210357.Report this figure246Total assets, Q2 FY2026, at 2026-06-30$246.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure
Current liabilities$m2.9Current liabilities, Q3 FY2023, at 2023-09-30$2.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-14, accession 0000950170-23-063675.Report this figure2.8Current liabilities, FY2023, at 2023-12-31$2.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-25, accession 0000950170-25-044350.Report this figure3.0Current liabilities, Q1 FY2024, at 2024-03-31$3.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0000950170-24-059995.Report this figure3.7Current liabilities, Q2 FY2024, at 2024-06-30$3.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0000950170-24-096626.Report this figure3.4Current liabilities, Q3 FY2024, at 2024-09-30$3.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125294.Report this figure4.9Current liabilities, FY2024, at 2024-12-31$4.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-05, accession 0001193125-26-092546.Report this figure7.0Current liabilities, Q1 FY2025, at 2025-03-31$7.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0000950170-25-070902.Report this figure6.2Current liabilities, Q2 FY2025, at 2025-06-30$6.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0000950170-25-106916.Report this figure4.9Current liabilities, Q3 FY2025, at 2025-09-30$4.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001193125-25-268086.Report this figure7.0Current liabilities, FY2025, at 2025-12-31$7.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure4.1Current liabilities, Q1 FY2026, at 2026-03-31$4.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-210357.Report this figure5.9Current liabilities, Q2 FY2026, at 2026-06-30$5.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure
Total liabilities$m3.0Total liabilities, Q3 FY2023, at 2023-09-30$3.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-14, accession 0000950170-23-063675.Report this figure2.9Total liabilities, FY2023, at 2023-12-31$2.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-25, accession 0000950170-25-044350.Report this figure3.0Total liabilities, Q1 FY2024, at 2024-03-31$3.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-15, accession 0000950170-24-059995.Report this figure3.7Total liabilities, Q2 FY2024, at 2024-06-30$3.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0000950170-24-096626.Report this figure3.4Total liabilities, Q3 FY2024, at 2024-09-30$3.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0000950170-24-125294.Report this figure5.3Total liabilities, FY2024, at 2024-12-31$5.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-05, accession 0001193125-26-092546.Report this figure7.4Total liabilities, Q1 FY2025, at 2025-03-31$7.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0000950170-25-070902.Report this figure6.6Total liabilities, Q2 FY2025, at 2025-06-30$6.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0000950170-25-106916.Report this figure5.3Total liabilities, Q3 FY2025, at 2025-09-30$5.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001193125-25-268086.Report this figure7.3Total liabilities, FY2025, at 2025-12-31$7.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure4.3Total liabilities, Q1 FY2026, at 2026-03-31$4.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001193125-26-210357.Report this figure6.7Total liabilities, Q2 FY2026, at 2026-06-30$6.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure
Shareholders' equity$m110Shareholders' equity, Q3 FY2023, at 2023-09-30$109.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0000950170-24-125294.Report this figure108Shareholders' equity, FY2023, at 2023-12-31$107.6m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-05, accession 0001193125-26-092546.Report this figure106Shareholders' equity, Q1 FY2024, at 2024-03-31$106.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268086.Report this figure222Shareholders' equity, Q2 FY2024, at 2024-06-30$222.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268086.Report this figure219Shareholders' equity, Q3 FY2024, at 2024-09-30$218.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268086.Report this figure212Shareholders' equity, FY2024, at 2024-12-31$211.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure193Shareholders' equity, Q1 FY2025, at 2025-03-31$193.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure186Shareholders' equity, Q2 FY2025, at 2025-06-30$185.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure177Shareholders' equity, Q3 FY2025, at 2025-09-30$177.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001193125-25-268086.Report this figure160Shareholders' equity, FY2025, at 2025-12-31$160.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure148Shareholders' equity, Q1 FY2026, at 2026-03-31$148.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure240Shareholders' equity, Q2 FY2026, at 2026-06-30$239.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure

Cash flow

Operating cash flow−$10.5m, Q2 FY2026
Capital expenditure$0, Q4 FY2025
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m3.5Operating cash flow, Q3 FY2023, three months to 2023-09-30$3.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0000950170-24-125294. Derived: 9-month figure less the 6-month figure.Report this figure(0.9)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$947.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-25, accession 0000950170-25-044350. Derived: 12-month figure less the 9-month figure.Report this figure(1.8)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$1.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0000950170-25-070902.Report this figure(0.7)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$667.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0000950170-25-106916. Derived: 6-month figure less the 3-month figure.Report this figure(7.6)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$7.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-268086. Derived: 9-month figure less the 6-month figure.Report this figure(5.5)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$5.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001193125-26-092546. Derived: 12-month figure less the 9-month figure.Report this figure(15.4)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$15.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-210357.Report this figure(11.1)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$11.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-336774. Derived: 6-month figure less the 3-month figure.Report this figure(12.1)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$12.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-268086. Derived: 9-month figure less the 6-month figure.Report this figure(15.6)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$15.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001193125-26-092546. Derived: 12-month figure less the 9-month figure.Report this figure(14.4)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$14.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-210357.Report this figure(10.5)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$10.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001193125-26-336774. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2024-11-12, accession 0000950170-24-125294. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2025-03-25, accession 0000950170-25-044350. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-268086. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001193125-26-092546. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$109.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-268086. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001193125-26-092546. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported

Shares

Diluted shares (weighted)76.15m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares26.3Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3026,336,029 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-14, accession 0000950170-23-063675.Report this figure26.5Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3126,492,438 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-15, accession 0000950170-24-059995.Report this figure26.8Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3026,840,555 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0000950170-24-096626.Report this figure27.1Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3027,071,053 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0000950170-24-125294.Report this figure27.6Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3127,638,528 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-14, accession 0000950170-25-070902.Report this figure30.3Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3030,349,562 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0000950170-25-106916.Report this figure67.0Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3067,014,183 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-268086.Report this figure67.5Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3167,462,450 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-210357.Report this figure67.6Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3067,585,121 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure68.0Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3068,003,248 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001193125-25-268086.Report this figure68.2Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3168,207,313 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-210357.Report this figure76.2Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3076,154,071 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure

Shares outstanding: 57.44mShares outstanding, period not labelled, at 2026-07-3157,436,255 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001193125-26-336774.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. Listed shows no prices and gives no investment advice.